Recent News

Share
and/or
Upcoming Seminars and Events

View upcoming seminars and events.

Learn more
519 News Items found
Blood samples being prepared for a centrifuge
MSK Research Highlights, ASH Annual Meeting 2022

Numerous developments in cellular therapy, multiple myeloma, leukemia and lymphoma are being presented by Memorial Sloan Kettering Cancer Center (MSK) researchers at the American Society of Hematology (ASH) Annual Meeting, which runs December 10-13.
MSK Postdoc Siting Gan
Sloan Kettering Institute Postdoc Spotlight: Siting Gan, Massagué and Pe'er Labs

Siting Gan has the heart of a rebel. Although she focused on physics in high school in Beijing, China, where she grew up, and chose to major in physics in college, she knew that she “wanted to do research and discover things myself.” That determination to pursue her own questions led her to biology and, ultimately, to a unique situation at Sloan Kettering Institute (SKI).
MSK Awards & Appointments November 2022

Memorial Sloan Kettering Cancer Center (MSK) announces the November 2022 awards and appointments.
Laboratory coats hanging from pegs
MSK Research Highlights, November 23, 2022

New research from Memorial Sloan Kettering Cancer Center (MSK) and the Sloan Kettering Institute finds tumor-associated macrophages that express a specific transcription factor might be targeted to improve immunotherapy; examines how different mutational processes impact individual cell genomes in cancer; sheds new light on cell senescence in cancer; and offers new models to aid the search for new treatments for mesothelioma.
MSK's Tobias Walther and Robert Farese, Jr.
Renowned Cellular Lipid and Energy Metabolism Researchers Join the Sloan Kettering Institute

Learn about renowned cellular lipid and energy metabolism researchers Robert Farese, Jr., and Tobias Walther who recently joined the Sloan Kettering Institute, running their lab jointly.
Memorial Sloan Kettering Cancer Center Tops Prestigious List of Highly Cited Researchers 2022
Memorial Sloan Kettering Cancer Center Tops Prestigious List of Highly Cited Researchers 2022

Memorial Sloan Kettering Cancer Center (MSK) is proud to announce that it is ranked among the top 15 organizations with the greatest number of highly cited scientific researchers worldwide, according to the annual list of Highly Cited Researchers published by the Institute for Scientific Information at Clarivate.
Postdocs Francisco “Pancho” Barriga and Kaloyan Tsanov in the lab
New MACHETE Technique Slices Into Cancer Genome To Study Copy Number Alterations

Learn why MSK researchers developed MACHETE, a new CRISPR-based technique to study large-scale genetic deletions efficiently in laboratory models.
A slide being reviewed under a microscope
MSK Research Highlights, October 13, 2022

New research from Memorial Sloan Kettering Cancer Center (MSK) and the Sloan Kettering Institute suggests a therapeutic strategy to overcome resistance to PRMT5 inhibition in lymphoma; finds safety and clinical benefit using an engineered adenovirus in combination with immunotherapy against PD-1-resistant melanoma; and uncovers a new type of immune cell that plays a key role in establishing a healthy gut microbiome.
MSK Postdoc Luis Felipe Somarribas Patterson in the lab
MSK Postdoc Spotlight: Luis Felipe Somarribas Patterson

Luis Felipe Somarribas Patterson joined the Santosha Vardhana Lab as a postdoc in 2021. He investigates how metabolism influences different cell types, including immune cells, and conducts research into “exhausted T cells,” a state of T cell dysfunction that arises during chronic infections and cancer.
Sloan Kettering Institute’s Alexander Gitlin
Sloan Kettering Institute’s Alexander Gitlin Honored with Prestigious NIH Director’s Early Independence Award

Sloan Kettering Institute’s (SKI) Alexander Gitlin, MD, PhD of Memorial Sloan Kettering Cancer Center (MSK) was recognized as a winner of the National Institutes of Health (NIH) Director’s Early Independence Award.